ArticleCureus2024
Multimodal Therapy for Locally Advanced Scrotal Cancer: A Case Report With a Literature Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer of the scrotum is a rare tumor. It is often not diagnosed early, and its treatment poses difficulties for practicing oncologists. We report the case of a patient treated for locally advanced squamous cell carcinoma (SCC) of the scrotum, with a review of the literature. It's about a 66-year-old man, who had been complaining two years ago of an ulcerated lesion at the scrotal region neglected by the patient. However, he presented with a large ulceration on the left inguinal region, for which, the pathological study showed an SCC. CT scan found a left inguinal tumoral process invading the adjacent soft tissues and infiltrating the left spermatic cord without distant localizations. Surgical excision of the inguinal lesion was considered unfeasible, then, an excision of the scrotal lesion was done and the pathological study identified an SCC of the scrotum with clear margins classified T1 N3 M0. Given that inguinal lymph node dissection (LND) was not feasible, concomitant chemo-radiotherapy was indicated at a total dose of 70 Gy in 35 fractions of 2 Gy concomitantly with weekly platinum-based chemotherapy, with good evolution after four months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.